Jobs / United States / Regeneron Pharmaceuticals INC
Associate Director Quantitative Pharmacology
Regeneron Pharmaceuticals INC · 🇺🇸 4 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles13 certified filings for “Associate Director Imaging” (Natural Sciences Managers) in NY: $201k–$281k, median $225k. Most were filed at wage level II (69%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
We are seeking a highly motivated Associate Director (AD) to join the Quantitative Pharmacology (QP) group. The Associate Director will lead model-informed drug development strategies supporting one or more therapeutic areas across modalities including antibodies, siRNA, and gene therapies. This role combines scientific depth with cross-functional leadership to inform dose selection, trial design, and regulatory strategy from early development through submission. When & where: • Work Location: Tarrytown, NY, Warren, NJ, Cambridge, MA or Remote, USA • Work model/flexibility: 4 days per week onsite or remote Discover your role: • Driving model-informed development (MIDD) and pharmacometrics strategies in partnership with Clinical Pharmacology, Biostatistics, Clinical and Translational teams to support regulatory and clinical decision-making. • Leading the Quantitative Pharmacology evaluation of one or more assets, accountable for timely delivery of population PK/PD, exposure–response, and translational modeling analyses. • Representing Quantitative Pharmacology at program and governance meetings, communicating quantitative insights clearly to non-modeling audiences. • Contributing to regulatory interactions and authoring key components of regulatory documents related to Quantitative Pharmacology (e.g., IB, briefing books, etc.). • Mentoring and developing junior scientists and fostering a culture of scientific rigor and collaboration. • Identifying and implementing process improvements, new modeling approaches, and innovative quantitative tools to enhance efficiency and impact. • Ensuring analyses and documentation are of the highest scientific quality and regulatory compliance. This may be the right role for you if you: • Want to make a visible impact on the organization by driving data-driven decisions that shape clinical and regulatory strategy. • Thrive in multi-disciplinary environments, bridging discovery, clinical, and commercial teams. • Communicate complex modeling concepts clearly and persuasively to diverse stakeholders. • Have strong collaboration and leadership skills, influencing cross-functional teams without formal authority. • Can independently design, execute, and oversee multiple modeling workstreams simultaneously. To be considered for this role, you must have: • PhD in Quantitative Pharmacology, Pharmacometrics, Engineering, or a related field with 7+ years of industry experience; or MS with 10+ years of relevant experience. • Demonstrated expertise in population PK/PD, exposure–response, or mechanistic modeling (systems biology, or QSP) using tools such as NONMEM, Monolix, Simulx, MATLAB/Simbiology and R. • Proven track record of delivering analyses supporting regulatory submissions and engaging directly with agencies (e.g., FDA, EMA, PMDA). • Hands-on experience with a broad range of quantitative and computational tools and a strong publication record. • Exceptional communication and interpersonal skills, with the ability to influence and partner effectively across technical and non-technical teams. Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other ch